Millions of Americans are turning to CBD as a go-to option instead of traditional drugs, especially for pain. A fresh study shows that about one in three people who have…
Arizona just greenlit a trailblazing clinical trial that could change lives for those battling post-traumatic stress disorder. This first-of-its-kind study dives into whole mushroom psilocybin as a treatment for PTSD…
A Senate committee is taking its conversation on veterans’ suicide and mental health out of Washington this week, choosing Alabama as the stage for a hearing that puts psychedelic therapies…
The newly appointed head of the DEA had pledged marijuana reform would top his list. That promise? Nowhere in sight. Terrence Cole was expected to make waves in Washington. Sworn…
A new study is giving fresh hope to eczema sufferers—especially those not thrilled about steroids. A topical cream containing cannabidiol (CBD) and cannabigerol (CBG) appears to significantly reduce itching and…
A senior U.S. Department of Veterans Affairs (VA) official has described Robert F. Kennedy Jr.'s position on psychedelics reform as a promising step forward, potentially paving the way for improved…
Former President Jimmy Carter’s funeral service on Thursday at the National Cathedral was not just a moment to mourn his passing but also to celebrate the enduring impact of his…
The Food and Drug Administration (FDA) has issued a stern warning to Anne’s Daye, the company behind CBD-coated tampons, citing concerns about safety, effectiveness, and regulatory compliance. The agency contends…
A new review published in the International Journal of Neuropsychopharmacology has highlighted cannabidiol (CBD) as a potential breakthrough in depression treatment. The report underscores CBD’s therapeutic promise, noting its antidepressant…
Some of the year’s most significant cannabis-related changes unfolded at the state level in 2024, with voters rejecting some legalization measures, while others saw the expansion of regulated markets. Amid…